Global market forces continue to drive life science companies to innovate and optimize clinical trials as costs, trial complexity and market change all increase. Clinical trial professionals responsible for IRT and trial supply need to rapidly adapt IRT design to accommodate novel and adaptive trials as well decentralized or hybrid trials while maintaining study flexibility and optimizing trial supply costs. To do this, technology support for supply chain management needs to be easy to use and future-proofed.

In this webinar, drug supply experts will discuss IRT functionality essential to managing and overcoming trial challenges. We’ll discuss what needs to be future-proofed, key integrations, and how automation and machine learning optimizes drug supply strategy. The panel of experts will explore IRT design best practices that facilitate innovative trials and how to:

  • Optimize buffer stock management and forecasting
  • Automate IRT supply strategy updates to reduce cost, risk and effort
  • Manage and oversee supply chain with flexible self-service tools and actionable insights
  • Support traditional, decentralized or hybrid trials with flexible IRT strategies
  • Enable IRT design best practices for complex and evolving trial designs